TruBridge (NASDAQ:TBRG) and 111 (NASDAQ:YI) Head-To-Head Review

TruBridge (NASDAQ:TBRG) and 111 (NASDAQ:YI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Risk & Volatility

TruBridge has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, 111 has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.

Insider & Institutional Ownership

88.6% of TruBridge shares are held by institutional investors. Comparatively, 21.3% of 111 shares are held by institutional investors. 10.7% of TruBridge shares are held by insiders. Comparatively, 43.9% of 111 shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares TruBridge and 111″s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$339.17 million	0.91	-$19.67 million	$0.19	108.76
111	$1.97 billion	0.02	-$1.42 million	($0.84)	-6.11

111 has higher revenue and earnings than TruBridge. 111 is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for TruBridge and 111, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	2	3	1	0	1.83
111	1	0	0	0	1.00

TruBridge presently has a consensus target price of $24.88, indicating a potential upside of 20.38%. Given TruBridge’s stronger consensus rating and higher probable upside, analysts clearly believe TruBridge is more favorable than 111.

Profitability

This table compares TruBridge and 111’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TruBridge	0.85%	12.23%	5.37%
111	-0.52%	N/A	-2.70%

Summary

TruBridge beats 111 on 11 of the 14 factors compared between the two stocks.

About TruBridge

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

About 111

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.